A Computational Operating System for Biology

LS-OS

Living Systems OS is a research and engineering program to make biology executable, intervention-aware, and reproducible.

Built by Kalman Labs for a new class of biological simulation infrastructure.

Executable

From molecular measurements to runnable disease dynamics

Perturbation-Aware

Simulate response under dose, schedule, and treatment changes

Reproducible

Versioned models, explicit assumptions, and auditable outputs

Core Thesis

Biology Should Be Run, Not Only Described.

Current State

  • High-dimensional data, low executable modeling capacity
  • Static models struggle under intervention shifts
  • Limited causal simulation for treatment planning

LS-OS Direction

  • Hybrid mechanistic-learning engines with explicit dynamics
  • Counterfactual simulation under intervention schedules
  • Reusable runtime interfaces across disease settings

Layer 1 MVP

Executable Tumor Response Dynamics in EGFR-mutant NSCLC

Start narrow, solve deeply. The first kernel of LS-OS is a hybrid model that maps RNA-seq to pathway state, pathway state to ODE parameters, and ODE simulation to resistance timing under EGFR TKI perturbations.

Input

Bulk RNA-seq and curated clinical progression outcomes

Abstraction

Pathway activity representation for intervention-relevant state

Dynamics

Constrained parameter net feeding differentiable tumor ODEs

Output

Trajectory behavior and resistance timing forecasts

Company Build Stack

Four Layers, One Direction

01

Disease Instance

EGFR NSCLC executable model as first verified kernel.

02

Reusable Framework

Hybrid ODE + ML architecture reusable across cohorts.

03

Runtime Engine

Standard interfaces for state, intervention, and simulation.

04

Platform Layer

Programmatic integration for therapy design and trial strategy.

Path Ahead

From EGFR Kernel to Biological Runtime

Phase A: Evidence

Complete rigorous EGFR benchmark package with ablations, calibration, and robustness.

Phase B: Generalization

Port the same engine to a second disease setting with minimal code changes.

Phase C: Infrastructure

Stabilize runtime APIs so intervention simulation becomes a reusable compute layer.

Collaborate in Research

Work With Kalman Labs on LS-OS

Cohort Studies

Joint retrospective analyses on NSCLC cohorts to test trajectory predictions.

Method Co-Development

Partner on model design, validation endpoints, and translational workflows.

Pilot Programs

Run practical pilots for treatment ranking and resistance-aware planning.